Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG
Clinical trial NCT04162600 · TERMINATED
Trial details
- NCT number
- NCT04162600
- Sponsor
- University of Oxford
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-02
- Primary completion
- 2024-07-10
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.